edge therapeutics inc » isaac blech menu isaac blech isaac blech has served as the vice chairman of edge therapeutics inc since january of  his current roles include founder and vice chairman of cerecor inc a private company developing new treatments for central nervous system disorders and director of contrafect corporation a private company developing therapies for infectious diseases since  he has served as vice chairman of premier alliance group a public company working in the areas of financial regulations clean energy and cyber security vice chairman of the spendsmart payments company a mobile marketing and payments company and director of medgenics inc a public company on the american stock exchange which has a new proprietary technology for providing protein therapies to patients with a wide range of illnesses he is also vice chairman of centrexion corporation a private company developing new modalities of pain control and vice chairman of restorgenex corporation a public company developing products in the areas of dermatology and restorative medicine over the past  years mr blech has founded some of the leading biotechnology companies including celgene corporation icos corporation pathogenesis corporation nova pharmaceutical corporation and genetic systems corporation these companies are responsible for major advances in oncology infectious disease and cystic fibrosis mr blech holds a ba from baruch college latest news edge therapeutics announces second quarter financial results conference call on august   read more precisa platform™ precisa™ our proprietary programmable biodegradable polymerbased development platform enables creation of polymerbased therapeutics capable of delivering directly to the site of injury read more eg our lead product candidate eg is currently in clinical development to improve patient outcomes versus standard of care after an asah resulting from a ruptured brain aneurysm read more edge therapeutics inc » isaac blech menu isaac blech isaac blech has served as the vice chairman of edge therapeutics inc since january of  his current roles include founder and vice chairman of cerecor inc a private company developing new treatments for central nervous system disorders and director of contrafect corporation a private company developing therapies for infectious diseases since  he has served as vice chairman of premier alliance group a public company working in the areas of financial regulations clean energy and cyber security vice chairman of the spendsmart payments company a mobile marketing and payments company and director of medgenics inc a public company on the american stock exchange which has a new proprietary technology for providing protein therapies to patients with a wide range of illnesses he is also vice chairman of centrexion corporation a private company developing new modalities of pain control and vice chairman of restorgenex corporation a public company developing products in the areas of dermatology and restorative medicine over the past  years mr blech has founded some of the leading biotechnology companies including celgene corporation icos corporation pathogenesis corporation nova pharmaceutical corporation and genetic systems corporation these companies are responsible for major advances in oncology infectious disease and cystic fibrosis mr blech holds a ba from baruch college latest news edge therapeutics announces second quarter financial results conference call on august   read more precisa platform™ precisa™ our proprietary programmable biodegradable polymerbased development platform enables creation of polymerbased therapeutics capable of delivering directly to the site of injury read more eg our lead product candidate eg is currently in clinical development to improve patient outcomes versus standard of care after an asah resulting from a ruptured brain aneurysm read more isaac blech  inspiremd home  about  board of directors  isaac blech isaac blech isaac blech is one of the most successful private financiers in the biotechnology industry over the past thirty five years he founded and served on the board of numerous companies which have produced major advances in a broad array of diseases including the diagnosis of chlamydia herpes syphilis and hiv and the treatment of cystic fibrosis sexual dysfunction multiple myeloma and many other cancers and hematological diseases companies established by mr blech include celgene corporation genetic systems corporation icos corporation nova pharmaceuticals corporation and pathogenesis corporation their combined value is approximately  billion mr blech is the vice chairman of edge therapeutics inc a public company developing novel therapies for lifethreatening neurological conditions he is a founder and vice chairman of cerecor inc a public company developing new treatments for central nervous system disorders and director of contrafect corporation a public company creating novel therapies for infectious diseases he is director of medgenics inc a public company which has a new proprietary technology for providing protein therapies to patients with a wide range of illnesses and vice chairman of centrexion corporation a private company developing new modalities of pain control he is vice chairman of x pharma a private cancer immunology company and vice chairman of waveguide a private company with the world’s smallest nmr machine mr blech is vice chairman of aridis a private company developing new treatments for pneumonia and other infectious diseases he is a founder and vice chairman of sapience therapeutics a private company with a new treatment for brain cancer and a founder and vice chairman of regenovation a private company in the field of regenerative medicine he is vice chairman of spendsmart a mobile marketing and payments company and vice chairman of rootb technologies a public company which is a leader in cybersecurity mr blech holds a ba from baruch college edge therapeutics inc » edge therapeutics appoints dr sol barer and isaac blech as chairman and vice chairman of its board of directors menu careers edge therapeutics appoints dr sol barer and isaac blech as chairman and vice chairman of its board of directors january   new providence nj–marketwire – january   – edge therapeutics inc announced today the appointment of isaac blech a leading biotechnology entrepreneur and investor as vice chairman of its board of directors separately the company announced that sol j barer phd who has served on the board since  will become chairman effective january   dr barer has more than  years of experience with publicly traded biotechnology companies at celgene corporation celg he spent  years leading celgene as president coo and ceo culminating with his tenure as celgene’s executive chairman and chairman before retiring in june  under his helm celgene became the third largest independent biotechnology company in the world and a member of the sp  with a current market capitalization exceeding  billion dr barer serves on the board of several companies including amicus therapeutics inc fold and aegerion pharmaceuticals inc aegr and is chairman of the board of cerecor inc contrafect corp inspiremd inc and medgenics inc mdgn over the past three decades mr blech has become one of the most successful private financiers in the biotechnology industry he has been instrumental in establishing some of the world’s leading biotechnology companies including celgene corporation genetic systems corporation icos corporation nova pharmaceutical corporation and pathogenesis corporation these companies are responsible for major advances in oncology infectious disease and cystic fibrosis current roles include founder vice chairman cerecor inc a private company developing new treatments for central nervous system disorders director contrafect corporation a private company developing therapies for infectious diseases vice chairman premier alliance group an energy and financial regulation consulting company director medgenics inc and vice chairman billmyparents inc an innovator in ecommerce for the youth market “we are honored to welcome mr blech to our board of directors and are extremely pleased that dr barer has agreed to take on additional responsibilities” said brian leuthner cofounder and ceo of edge therapeutics “we are confident that with their guidance edge can build a commercial biopharmaceutical company wellpositioned to develop valuable and potentially lifesaving therapies that address complications after ruptured brain aneurysms subdural hematomas and other types of brain hemorrhage” “edge is seeking to build novel products using a site specific sustained release microparticle technology platform” said isaac blech “i am delighted to help edge therapeutics build the capabilities and organizational structure needed to carry its products through clinical trials regulatory approval and ultimately to the patients who can benefit from these therapies” about edge therapeutics edge therapeutics is a clinicalstage hospitalfocused biopharmaceutical company that uses its novel sitespecific and sustainedrelease microparticle technology platform to deliver drugs to the brain to prevent complications occurring after subarachnoid hemorrhage subdural hematoma and intracerebral hemorrhage all of which currently have minimally effective or no effective therapies edge works with some of the world’s foremost scientists and critical care physicians from leading academic research centers to develop proprietary formulations of known active drugs for direct therapeutic delivery to the site of injury in the brain the company’s patentpending bioabsorbable microparticle formulations release drugs locally and consistently at therapeutic concentrations in the brain with the objective of maximizing therapeutic activity and avoiding treatmentlimiting systemic side effects seen with current treatments currently oral or ivadministered therapies are employed but in suboptimal concentrations due to the generation of systemic side effects edge’s lead products eg nimodipine microparticles and eg are being developed to prevent various delayed complications after brain hemorrhage eg is a proprietary microparticle formulation of the generic calcium channel blocker nimodipine while eg delivers a hemostatic agent for more information on edge therapeutics inc please visit edgetherwpenginecom for more information contact edge therapeutics inc brian a leuthner president  ceo edge latest news edge therapeutics announces second quarter financial results conference call on august   read more precisa platform™ precisa™ our proprietary programmable biodegradable polymerbased development platform enables creation of polymerbased therapeutics capable of delivering directly to the site of injury read more eg our lead product candidate eg is currently in clinical development to improve patient outcomes versus standard of care after an asah resulting from a ruptured brain aneurysm read more a biotech king dethroned  the new york times nytimescom no longer supports internet explorer  or earlier please upgrade your browser learn more » sections home search skip to content skip to navigation view mobile version the new york times business daya biotech king dethroned search subscribe now log in  settings close search httpsnytimsglrw advertisement supported by business day a biotech king dethroned by andrew pollacksept   continue reading the main story share this page continue reading the main story photo “there’s no question that if i had been in a coma for the last  years i would wake up a billionaire today” david blech credit robert caplin for the new york times he was once hailed as the king of biotechnology in the industry’s frontier days david blech was the top gunslinger quick to draw his checkbook to start new companies or prop up faltering onesmr blech was the initial financial force behind the industry giant celgene the rare disease specialist alexion pharmaceuticals and the cancer drug developer ariad pharmaceuticals not to mention icos which developed the impotence pill cialisin the early s mr blech was worth about  million and made the forbes list of  wealthiest americansnow however he is about to begin a fouryear prison term about  million in debt and mainly an afterthought to the industry he helped foster advertisement continue reading the main story he squandered his fortune with reckless borrowing and stock trading in a quest for even greater riches his wall street firm d blech  company collapsed — dragging biotech share prices down with it — in  on a day some called “blech thursday” comeback attempts have only gotten him deeper into trouble continue reading the main story advertisement continue reading the main story “there’s no question that if i had been in a coma for the last  years i would wake up a billionaire today” mr blech  saidbesides what his downfall means for his personal life it reflects the maturation of the biotechnology industry from its getrichquick days when someone like mr blech a music major with no scientific training could make a difference with a few million dollars now billions are invested by funds managed by teams of doctors and scientists with phd’smr blech pronounced bleck is to report on sept  to federal prison in fort dix nj having pleaded guilty to manipulating the stock of two biotech companies as part of his latest comeback attempt he also pleaded guilty to securities fraud in  but avoided prisonin an interview at his manhattan apartment mr blech said he hoped to be remembered for helping to create an industry that has saved liveshe said his reckless behavior stemmed in part from bipolar disorder which left him at times feeling invincible and unable to restrain himself“i didn’t know how to say no to a deal” he saidcritics over the years have said mr blech was merely an aggressive stock promoter who got lucky they note that celgene and alexion did not become successful until long after mr blech was associated with them photo mr blech who pleaded guilty to stock manipulation at his manhattan apartment in july credit robert caplin for the new york times but mr blech still has supporters nick arvanitidis recalled that in  his company liposome technology was desperate for cash other investors spurned him he said but “david just wrote me a check for  million the same day i went to see him” that allowed liposome to survive and develop doxil an important cancer drug advertisement continue reading the main story jeffrey j collinson a venture capitalist said mr blech saved several companies “it’s painful to hear what happened and how he got into this position” mr collinson said “it’s a sad story”it is also an unlikely story in  mr blech was working as a stockbroker while trying to become a songwriter that fall biotechnology pioneer genentech went public and its share price doubled the first day“i can do that” mr blech then only  told his father a rabbi who was also a stockbroker mr blech then called his brother isaac who was working in advertising and said “quit your job we’re starting a genetics company”sitting around the kitchen table the three came up with a name — genetic systems then they had to figure out what the company would actually doan article in a science magazine led them to robert nowinski at the fred hutchinson cancer research center in seattle who was doing research on a new technology involving something called monoclonal antibodiesthe blechs promised dr nowinski  and then raised  million from others half a year later genetic systems went public and the blechs’ stake was worth  million in  bristolmyers squibb acquired genetic systems for nearly  million and the blechs were richer stilldavid and isaac blech went on to form several other companies some of which ultimately failed they attracted top scientists directors and advisers by offering them stock and a chance to get rich the companies were often taken public quickly so the blechs and other early shareholders could realize a return newsletter sign up continue reading the main story please verify youre not a robot by clicking the box invalid email address please reenter you must select a newsletter to subscribe to sign up you agree to receive occasional updates and special offers for the new york timess products and services thank you for subscribing an error has occurred please try again later you are already subscribed to this email view all new york times newsletters see sample manage email preferences not you privacy policy opt out or contact us anytime things began going wrong around  when mr blech wanted to expand while his more cautious brother wanted to take a hiatus the brothers had a rancorous split and have essentially not talked sincemr blech started d blech  company which underwrote stock offerings when biotechnology stocks he was involved with weakened he tried to prop them up by buying more shares using  million in borrowed money when creditors started calling in the loans a desperate mr blech started engaging in sham trades to make it look as if he was getting his house in order advertisement continue reading the main story d blech  company collapsed on sept   emotionally broken mr blech checked himself into a hospital psychiatric ward for a brief stay his wife filed for divorce his remaining holdings — including a stake in alexion that would be worth more than  billion today — were sold off for about  million to pay creditorsbut instead of going to prison mr blech was sentenced to five years’ probation because of his bipolar disorder and his cooperation with the government photo mr blech at his apartment building’s basement pool in  credit harley soltesthe seattle times “god forbid you should ever come back to this courtroom” judge kevin t duffy said at the sentencing in  mr blech “solemnly pledged” that he would notby the time his probation ended his old formula would not work the  million or so he had sheltered in trusts for his children no longer went so far startups could no longer go public just because they had “genetic” in their names and companies did not want financing from a felonso mr blech turned to hardpressed penny stock companies government investigators said he reverted to past behavior trading through more than  nominee accounts in the name of his new wife other relatives even a yeshiva run by a cousinin court proceedings and documents mr blech said he was so convinced that pluristem therapeutics an israeli stem cell company would be successful that he spent  million some of it borrowed on its shares in  he said he had to sell the shares to repay the loan but feared that such a huge sale of a thinly traded stock would cause the price to collapseso according to prosecutors mr blech sold shares through some nominee accounts and bought shares through others gradually reducing his holdings while making it appear there was an active market for the stockprosecutors said the scheme allowed him to sell the shares for  million when he might otherwise have gotten nothing it accused mr blech of a similar plot involving intellect neurosciences advertisement continue reading the main story in  mr blech pleaded guilty to two counts of securities fraud once again he asked for mercy citing his bipolar disease his contributions to medicine and the hardship a prison sentence would impose on his family including an autistic sonbut the judge colleen mcmahon said the time for leniency had passed“i bleed for your family your wife your kids” she told him at the sentencing hearing in may “it’s a terrible thing you have done to them not me i am not doing it to them you did it to them they will have to survive”in addition to the fouryear sentence she ordered him to forfeit  million last month mr blech agreed to pay an additional  million to settle with the securities and exchange commissionmr blech is appealing his sentence saying it is excessive since he actually lost  million on his investment in pluristem but the appeal is not likely to be heard until he is already in prison“i made my money legitimately and i lost it illegitimately” mr blech saidhe says that he wants to turn over a new leaf and that with the help of gamblers anonymous he has not traded a stock in two yearsbut he is still hoping for one more successful investment — from a remaining sizable stake in intellect neurosciences the company has a market valuation of only  million but mr blech said that if a drug for alzheimer’s disease showed some promise in animal testing intellect could be acquired for a much larger sum“if it works out we’re out of trouble and i can pay my fines” he said “it’s about hanging on” continue reading the main story we’re interested in your feedback on this page tell us what you think whats next loading go to home page » site index the new york times leading biotechnology entrepreneur and investor isaac blech joins medgenics board of directors  business wire leading biotechnology entrepreneur and investor isaac blech joins medgenics board of directors june    am eastern daylight time misgav israel  vienna vabusiness wiremedgenics inc nyse amex mdgn and aim medu medg today announced that isaac blech age  a leading biotechnology entrepreneur and investor has joined the company’s board of directors mr blech has served on the company’s strategic advisory board since february  and is a major investor in the company having invested over  million in the company over the past year the medgenics board of directors now has seven members mr blech is one of the most successful private financiers in the biotechnology industry as an industry pioneer he founded seven companies all of which were subsequently brought public these include celgene corporation genetic systems corporation icos corporation nova pharmaceuticals corporation and pathogenesis corporation these companies are responsible for major advances in a number of diseases including the diagnosis andor treatment of cancer chlamydia sexual dysfunction cystic fibrosis and aids their combined value is in excess of  billion mr blech is a major shareholder and a director of socialwise inc an innovator in ecommerce for the youth market and is also a major shareholder and director of contrafect corporation a company developing therapies for infectious diseases mr blech is also a major shareholder of the public companies premier alliance group a financial consulting company and stratus media group an owner producer promoter and operator of live entertainment events mr blech is also a founder director and major shareholder of cerecor inc a private company developing new treatments for central nervous system disorders “it is with great pleasure that we welcome isaac to our board of directors isaac’s indepth experience in biotechnology commercialization and his impressive professional network should be instrumental in helping us build medgenics into a leading biotechnology company pioneering personalized sustained therapy using our biopump platform for continuous production and delivery of therapeutic proteins by the patient’s own skin we look forward to isaac’s active involvement and support as a director as we advance our platform technology toward commercialization in a number of chronic diseases” stated andrew l pearlman phd president and ceo of medgenics commenting on his appointment isaac blech said “medgenics is demonstrating its ability to use a patient’s own tissue to create biopumps that when inserted back into that patient are designed to deliver sustained production of the desired protein this is potentially a major scientific and medical breakthrough which has the ability to change the treatment paradigm across a range of chronic diseases i am delighted to be working with the medgenics team and look forward to guiding them in the successful clinical development and commercialization of this powerful technology” about medgenics medgenics is developing and commercializing biopump a proprietary tissuebased platform technology for the sustained production and delivery of therapeutic proteins using the patient’s own skin biopsy for the treatment of a range of chronic diseases including anemia hepatitis c and hemophilia medgenics believes this approach has multiple benefits compared with current treatments which include regular and costly injections of therapeutic proteins medgenics has three longacting protein therapy products in development based on this technology epodure now completing a phase iii doseranging trial to produce and deliver erythropoietin for many months from a single administration has demonstrated elevation and stabilization of hemoglobin levels in anemic patients for  to more than  months infradure to commence a phase iii trial in israel in  to produce a sustained therapeutic dose of interferonalpha for use in the treatment hepatitis c hemodure is a sustained factor viii therapy for the prophylactic treatment of hemophilia now in development medgenics intends to develop its innovative products and bring them to market via strategic partnerships with major pharmaceutical andor medical device companies since october  hemodure has been the focus of cooperation between medgenics and a major healthcare company a market leader in hemophilia in addition to treatments for anemia hepatitis c and hemophilia medgenics plans to develop andor outlicense a pipeline of future biopump products targeting the large and rapidly growing global protein therapy market which is forecast to reach  billion in  other potential applications for biopumps include multiple sclerosis arthritis pediatric growth hormone deficiency obesity and diabetes forwardlooking statements this release contains forwardlooking statements within the meaning of section a of the securities act of  section e of the securities exchange act of  and as that term is defined in the private securities litigation reform act of  which include all statements other than statements of historical fact including without limitation those regarding the companys financial position its development and business strategy its product candidates and the plans and objectives of management for future operations the company intends that such forwardlooking statements be subject to the safe harbors created by such laws forwardlooking statements are sometimes identified by their use of the terms and phrases such as estimate project intend forecast anticipate plan planning expect believe will will likely should could would may or the negative of such terms and other comparable terminology all such forwardlooking statements are based on current expectations and are subject to risks and uncertainties should any of these risks or uncertainties materialize or should any of the companys assumptions prove incorrect actual results may differ materially from those included within these forwardlooking statements accordingly no undue reliance should be placed on these forwardlooking statements which speak only as of the date made the company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forwardlooking statements contained herein to reflect any change in the companys expectations with regard thereto or any change in events conditions or circumstances on which any such statements are based as a result of these factors the events described in the forwardlooking statements contained in this release may not occur contacts medgenics incdr andrew l pearlman orlippertheilshorn  associates incanne marie fields afieldslhaicomorde facto financialmike wort anna dunphyorreligare capital markets nomadjames pinner derek crowhurstorsvs securities plc joint brokeralex mattey ian callawayornomura code securities joint brokerjonathan senior  contacts medgenics incdr andrew l pearlman orlippertheilshorn  associates incanne marie fields afieldslhaicomorde facto financialmike wort anna dunphyorreligare capital markets nomadjames pinner derek crowhurstorsvs securities plc joint brokeralex mattey ian callawayornomura code securities joint brokerjonathan senior  search advanced news search advanced news search log in sign up david blech  wikipedia david blech from wikipedia the free encyclopedia jump to navigation search david abraham blech born november   is an american businessman investor and venture capitalist he is one of the financial pioneers of the biotech industry and was once known as the king of biotech contents  early life and education  early career  personal  references early life and educationedit blech graduated from baruch college and earned a masters in music education at the teachers college of columbia university early careeredit since  mr blech has been a founder of companies and venture capital investor in the biotechnology sector his initial venture investment genetic systems corporation which he helped found with his father and his brother isaac blech was built around promising scientists including the high profile microbiologist robert nowinski it developed the first inexpensive and accurate test to diagnosis sexuallytransmitted diseases using monoclonal antibodies allowing tens of thousands of babies to be born to women who otherwise would have become sterile from pelvic inflammatory disease the company was sold to bristol myers in  for  million  of bristol myers stock in  blech cofounded icos corporation with nowinski and george b rathmann receiving the largest start up financing in biotech history at  million icos discovered the drug cialis which was acquired by eli lilly in  for over  billion the blechs also cofounded celgene corporation in  which was a unit of the celanese corporation and was spun off as an independent company following the merger of celanese corporation with american hoechst corporation celgene introduced two major cancer drugs and has a current value of over  billion making it the th largest biotech company in the world other companies he helped found include dna plant technology neurogen corporation incyte pharmaceuticals alexion pharmaceuticals ariad pharmaceuticals neurocrine biosciences cytosorbents inc and intellect neurosciences he was also instrumental in the turnaround of liposome technology inc and biotech general corporation in  mr blech founded d blech  company which until it ceased doing business in september  was a registered brokerdealer involved in underwriting biotechnology issues at his peak in  blechs wealth was estimated at almost  million briefly making him a member of the forbes  falling deep into debt d blech  co was in violation of net capital rules and ceased operations on september   a day that came to be known as blech thursday in the biotech industry blech came under investigation by the sec for securities fraud during the investigation lloyd schwed a floridabased attorney representing a group of former brokers attempted to blackmail blech by promising to withhold tapes subpoenaed during the investigation blech became an informant in exchange for leniency he pleaded guilty to two counts of criminal fraud and was sentenced to a fiveyear term of probation personaledit blech says he is bipolar has a gambling addiction and is a member of gamblers anonymous referencesedit  bylinsky gene  june  what a way to start a company a pharmaceuticals giant has put more than  million into nova a fledgling outfit that didnt even have a lab before it went public  and still hasnt marketed a product cnn   httpwwwlifesciencesfoundationorgeventsgeneticsystemsinchtml  walters donna  february  bristolmyers agrees to buy genetic systems  syntex bought out of deal with biotech firm bristolmyers agrees to buy genetic systems  syntex bought out of deal with biotech firm los angeles times retrieved  february    a b c duff wilson david heath he helped create the biotech boom and when it went bust so did he uninformed consent seattle times retrieved  february    httpwwwzoominfocomsearchprofilepersonpersonidtargetidprofile  william p barrett janet novack daniel fisher matthew rand and starting to bark and starting to bark forbescom retrieved  february    pollack andrew  september  a biotech king dethroned the new york times   david blech gets four years for manipulating stock prices bloomberg  retrieved from httpsenwikipediaorgwindexphptitledavidblecholdid categories  birthsamerican investorsamerican businesspeoplepeople from brooklynteachers college columbia university alumniliving peoplebaruch college alumniamerican businesspeople convicted of crimes navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view david blech  wikipedia david blech from wikipedia the free encyclopedia jump to navigation search david abraham blech born november   is an american businessman investor and venture capitalist he is one of the financial pioneers of the biotech industry and was once known as the king of biotech contents  early life and education  early career  personal  references early life and educationedit blech graduated from baruch college and earned a masters in music education at the teachers college of columbia university early careeredit since  mr blech has been a founder of companies and venture capital investor in the biotechnology sector his initial venture investment genetic systems corporation which he helped found with his father and his brother isaac blech was built around promising scientists including the high profile microbiologist robert nowinski it developed the first inexpensive and accurate test to diagnosis sexuallytransmitted diseases using monoclonal antibodies allowing tens of thousands of babies to be born to women who otherwise would have become sterile from pelvic inflammatory disease the company was sold to bristol myers in  for  million  of bristol myers stock in  blech cofounded icos corporation with nowinski and george b rathmann receiving the largest start up financing in biotech history at  million icos discovered the drug cialis which was acquired by eli lilly in  for over  billion the blechs also cofounded celgene corporation in  which was a unit of the celanese corporation and was spun off as an independent company following the merger of celanese corporation with american hoechst corporation celgene introduced two major cancer drugs and has a current value of over  billion making it the th largest biotech company in the world other companies he helped found include dna plant technology neurogen corporation incyte pharmaceuticals alexion pharmaceuticals ariad pharmaceuticals neurocrine biosciences cytosorbents inc and intellect neurosciences he was also instrumental in the turnaround of liposome technology inc and biotech general corporation in  mr blech founded d blech  company which until it ceased doing business in september  was a registered brokerdealer involved in underwriting biotechnology issues at his peak in  blechs wealth was estimated at almost  million briefly making him a member of the forbes  falling deep into debt d blech  co was in violation of net capital rules and ceased operations on september   a day that came to be known as blech thursday in the biotech industry blech came under investigation by the sec for securities fraud during the investigation lloyd schwed a floridabased attorney representing a group of former brokers attempted to blackmail blech by promising to withhold tapes subpoenaed during the investigation blech became an informant in exchange for leniency he pleaded guilty to two counts of criminal fraud and was sentenced to a fiveyear term of probation personaledit blech says he is bipolar has a gambling addiction and is a member of gamblers anonymous referencesedit  bylinsky gene  june  what a way to start a company a pharmaceuticals giant has put more than  million into nova a fledgling outfit that didnt even have a lab before it went public  and still hasnt marketed a product cnn   httpwwwlifesciencesfoundationorgeventsgeneticsystemsinchtml  walters donna  february  bristolmyers agrees to buy genetic systems  syntex bought out of deal with biotech firm bristolmyers agrees to buy genetic systems  syntex bought out of deal with biotech firm los angeles times retrieved  february    a b c duff wilson david heath he helped create the biotech boom and when it went bust so did he uninformed consent seattle times retrieved  february    httpwwwzoominfocomsearchprofilepersonpersonidtargetidprofile  william p barrett janet novack daniel fisher matthew rand and starting to bark and starting to bark forbescom retrieved  february    pollack andrew  september  a biotech king dethroned the new york times   david blech gets four years for manipulating stock prices bloomberg  retrieved from httpsenwikipediaorgwindexphptitledavidblecholdid categories  birthsamerican investorsamerican businesspeoplepeople from brooklynteachers college columbia university alumniliving peoplebaruch college alumniamerican businesspeople convicted of crimes navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view david blech  wikipedia david blech from wikipedia the free encyclopedia jump to navigation search david abraham blech born november   is an american businessman investor and venture capitalist he is one of the financial pioneers of the biotech industry and was once known as the king of biotech contents  early life and education  early career  personal  references early life and educationedit blech graduated from baruch college and earned a masters in music education at the teachers college of columbia university early careeredit since  mr blech has been a founder of companies and venture capital investor in the biotechnology sector his initial venture investment genetic systems corporation which he helped found with his father and his brother isaac blech was built around promising scientists including the high profile microbiologist robert nowinski it developed the first inexpensive and accurate test to diagnosis sexuallytransmitted diseases using monoclonal antibodies allowing tens of thousands of babies to be born to women who otherwise would have become sterile from pelvic inflammatory disease the company was sold to bristol myers in  for  million  of bristol myers stock in  blech cofounded icos corporation with nowinski and george b rathmann receiving the largest start up financing in biotech history at  million icos discovered the drug cialis which was acquired by eli lilly in  for over  billion the blechs also cofounded celgene corporation in  which was a unit of the celanese corporation and was spun off as an independent company following the merger of celanese corporation with american hoechst corporation celgene introduced two major cancer drugs and has a current value of over  billion making it the th largest biotech company in the world other companies he helped found include dna plant technology neurogen corporation incyte pharmaceuticals alexion pharmaceuticals ariad pharmaceuticals neurocrine biosciences cytosorbents inc and intellect neurosciences he was also instrumental in the turnaround of liposome technology inc and biotech general corporation in  mr blech founded d blech  company which until it ceased doing business in september  was a registered brokerdealer involved in underwriting biotechnology issues at his peak in  blechs wealth was estimated at almost  million briefly making him a member of the forbes  falling deep into debt d blech  co was in violation of net capital rules and ceased operations on september   a day that came to be known as blech thursday in the biotech industry blech came under investigation by the sec for securities fraud during the investigation lloyd schwed a floridabased attorney representing a group of former brokers attempted to blackmail blech by promising to withhold tapes subpoenaed during the investigation blech became an informant in exchange for leniency he pleaded guilty to two counts of criminal fraud and was sentenced to a fiveyear term of probation personaledit blech says he is bipolar has a gambling addiction and is a member of gamblers anonymous referencesedit  bylinsky gene  june  what a way to start a company a pharmaceuticals giant has put more than  million into nova a fledgling outfit that didnt even have a lab before it went public  and still hasnt marketed a product cnn   httpwwwlifesciencesfoundationorgeventsgeneticsystemsinchtml  walters donna  february  bristolmyers agrees to buy genetic systems  syntex bought out of deal with biotech firm bristolmyers agrees to buy genetic systems  syntex bought out of deal with biotech firm los angeles times retrieved  february    a b c duff wilson david heath he helped create the biotech boom and when it went bust so did he uninformed consent seattle times retrieved  february    httpwwwzoominfocomsearchprofilepersonpersonidtargetidprofile  william p barrett janet novack daniel fisher matthew rand and starting to bark and starting to bark forbescom retrieved  february    pollack andrew  september  a biotech king dethroned the new york times   david blech gets four years for manipulating stock prices bloomberg  retrieved from httpsenwikipediaorgwindexphptitledavidblecholdid categories  birthsamerican investorsamerican businesspeoplepeople from brooklynteachers college columbia university alumniliving peoplebaruch college alumniamerican businesspeople convicted of crimes navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view david blech  wikipedia david blech from wikipedia the free encyclopedia jump to navigation search david abraham blech born november   is an american businessman investor and venture capitalist he is one of the financial pioneers of the biotech industry and was once known as the king of biotech contents  early life and education  early career  personal  references early life and educationedit blech graduated from baruch college and earned a masters in music education at the teachers college of columbia university early careeredit since  mr blech has been a founder of companies and venture capital investor in the biotechnology sector his initial venture investment genetic systems corporation which he helped found with his father and his brother isaac blech was built around promising scientists including the high profile microbiologist robert nowinski it developed the first inexpensive and accurate test to diagnosis sexuallytransmitted diseases using monoclonal antibodies allowing tens of thousands of babies to be born to women who otherwise would have become sterile from pelvic inflammatory disease the company was sold to bristol myers in  for  million  of bristol myers stock in  blech cofounded icos corporation with nowinski and george b rathmann receiving the largest start up financing in biotech history at  million icos discovered the drug cialis which was acquired by eli lilly in  for over  billion the blechs also cofounded celgene corporation in  which was a unit of the celanese corporation and was spun off as an independent company following the merger of celanese corporation with american hoechst corporation celgene introduced two major cancer drugs and has a current value of over  billion making it the th largest biotech company in the world other companies he helped found include dna plant technology neurogen corporation incyte pharmaceuticals alexion pharmaceuticals ariad pharmaceuticals neurocrine biosciences cytosorbents inc and intellect neurosciences he was also instrumental in the turnaround of liposome technology inc and biotech general corporation in  mr blech founded d blech  company which until it ceased doing business in september  was a registered brokerdealer involved in underwriting biotechnology issues at his peak in  blechs wealth was estimated at almost  million briefly making him a member of the forbes  falling deep into debt d blech  co was in violation of net capital rules and ceased operations on september   a day that came to be known as blech thursday in the biotech industry blech came under investigation by the sec for securities fraud during the investigation lloyd schwed a floridabased attorney representing a group of former brokers attempted to blackmail blech by promising to withhold tapes subpoenaed during the investigation blech became an informant in exchange for leniency he pleaded guilty to two counts of criminal fraud and was sentenced to a fiveyear term of probation personaledit blech says he is bipolar has a gambling addiction and is a member of gamblers anonymous referencesedit  bylinsky gene  june  what a way to start a company a pharmaceuticals giant has put more than  million into nova a fledgling outfit that didnt even have a lab before it went public  and still hasnt marketed a product cnn   httpwwwlifesciencesfoundationorgeventsgeneticsystemsinchtml  walters donna  february  bristolmyers agrees to buy genetic systems  syntex bought out of deal with biotech firm bristolmyers agrees to buy genetic systems  syntex bought out of deal with biotech firm los angeles times retrieved  february    a b c duff wilson david heath he helped create the biotech boom and when it went bust so did he uninformed consent seattle times retrieved  february    httpwwwzoominfocomsearchprofilepersonpersonidtargetidprofile  william p barrett janet novack daniel fisher matthew rand and starting to bark and starting to bark forbescom retrieved  february    pollack andrew  september  a biotech king dethroned the new york times   david blech gets four years for manipulating stock prices bloomberg  retrieved from httpsenwikipediaorgwindexphptitledavidblecholdid categories  birthsamerican investorsamerican businesspeoplepeople from brooklynteachers college columbia university alumniliving peoplebaruch college alumniamerican businesspeople convicted of crimes navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view isaac blech  new york ny  intelius sign in we found isaac blech in new york ny isaac blech intelius found that isaac blech from new york ny we have connected them to  addresses  phones and  relatives or associates get report now isaac has lived in new york ny yonkers ny charlotte nc isaacs relatives david blech miriam blech rina blech michael blech isaac blech professional status vice chairman of the board at rootb get report now want to know more about isaac get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about isaac or use our people search engine to find others get background check on isaac blech get a criminal check on isaac blech get a public record report on isaac blech get a people search report on isaac blech isaac blechs contact information known cities lived in find out where isaac blech has lived as well as isaac blechs phone numbers and email addresses isaac blech has lived in  states new york address for isaac blech  s e a new york ny has lived in new york ny yonkers ny get full address report phone numbers associated with isaac blech    yonkers ny    new york ny    charlotte nc get full phone report email addresses associated with isaac blech ihcom iccom ihcom get email report isaac blechs professional information information regarding isaac blechs professional history find out previous places isaac blech has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act isaac blech has worked at  places company rootb title vice chairman of the board company contrafect corporation title board member isaac blechs experience title vice chairman of the board company rootb job details company size  mil to less than  mil  employee range  to less than  title board member company contrafect corporation job details company size  mil to less than  mil  employee range less than  contrafect is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for lifethreatening drugresistant infectious diseases particularly those treated in hospital settings an estimated  deaths worldwide each year are attributed to antimicrobialresistant infections we intend to address life threatening infections using our therapeutic product candidates from our lysin and monoclonal antibody platforms to target conserved regions of either bacteria or viruses regions that are not prone to mutation contrafects initial product candidates include new agents to treat antibioticresistant infections such as mrsa methicillinresistant staphylococcus aureus and influenza additional professional information on isaac blech see isaac blechs linkedin profile isaac blechs social network and potential email matches find out potential social network profiles and potential email usernamed for isaac blech isaac blechs known social networks and potential email matches find all of isaac blechs social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches isaac blech username matches isaacblech blechisaac isaacblech blechisaac isaacblech blechisaac isaacblech blechisaac iblech popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches i blech intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here isaac blech  cerecor inc  zoominfocom insider trading  blech isaac  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  blech isaac select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  am medgenics inc mdgn blech isaacdirector owner    directindirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm  cerecor inc cerc blech isaacdirector   direct view option award  am na inspiremd inc nspr blech isaacdirector   direct view option award  pm na cerecor inc cerc blech isaacdirector   direct view option award  pm na diffusion pharmaceuticals inc dffn blech isaacdirector   direct view option award  pm  rootb technologies inc rtnb blech isaacdirector owner   direct view option award  pm nana spendsmart networks inc sspc blech isaacdirector   direct view option award  am  inspiremd inc nspr blech isaacdirector   direct view option award  pm na cerecor inc cerc blech isaacdirector   direct view option award  am  edge therapeutics inc edge blech isaacdirector   direct view disposition  pm na rootb technologies inc rtnb blech isaacdirector owner   direct view option award  pm na rootb technologies inc rtnb blech isaacdirector owner   direct view option award  am na cerecor inc cerc blech isaacdirector   direct view option award  pm na inspiremd inc nspr blech isaacdirector   direct view option award  pm  medgenics inc mdgn blech isaacdirector   direct view option award  pm na spendsmart networks inc sspc blech isaacdirector   direct view option award  am  rootb technologies inc rtnb blech isaacdirector owner   direct view option award  pm  spendsmart networks inc sspc blech isaacdirector owner   direct view option award  pm  spendsmart networks inc sspc blech isaacdirector owner   indirect view disposition  pm na spendsmart networks inc sspc blech isaacdirector owner   direct view option award  pm na spendsmart networks inc sspc blech isaacdirector owner   direct view option award  am na cerecor inc cerc blech isaacdirector   direct view conversion  pm nana cerecor inc cerc blech isaacdirector owner   direct view conversion  pm nana cerecor inc cerc blech isaacdirector owner   indirect view conversion  pm nana cerecor inc cerc blech isaacdirector owner   direct view conversion  pm nana cerecor inc cerc blech isaacdirector owner   indirect view exercise  am nana medgenics inc mdgn blech isaacdirector owner   indirect view exercise  am  medgenics inc mdgn blech isaacdirector owner   indirect view disposition  pm na spendsmart networks inc sspc blech isaacdirector owner   direct view disposition  pm na spendsmart networks inc sspc blech isaacdirector owner   direct view disposition  pm na spendsmart networks inc sspc blech isaacdirector owner   direct view disposition  pm na spendsmart networks inc sspc blech isaacdirector owner   direct view option award  pm na spendsmart networks inc sspc blech isaacdirector owner   direct view option award  pm na spendsmart networks inc sspc blech isaacdirector owner   direct view option award  pm na restorgenex corp resx blech isaacdirector   direct view expired  pm na rootb technologies inc rtnb blech isaacblech miriamriver charitable remainder unitrust fbo isaac blechdirector owner   direct view option award  pm  rootb technologies inc rtnb blech isaacblech miriamriver charitable remainder unitrust fbo isaac blechdirector owner   direct view expired  pm na rootb technologies inc rtnb blech isaacblech miriamriver charitable remainder unitrust fbo isaac blechdirector owner   indirect view option award  pm  rootb technologies inc rtnb blech isaacblech miriamriver charitable remainder unitrust fbo isaac blechdirector owner   indirect view option award  am na medgenics inc mdgn blech isaacdirector   direct view   secformcom all rights reserved archives        wed  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  blech isaac top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active blech isaac • boston ma how do i update this listing blech isaac is based out of boston whalewisdom has at least  dg filings and  insider transactions form  in our database for blech isaac summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from blech isaac enter your email address below and choose submit your email cancel contact info blech isaac co inspiremd inc boston ma     recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  current dg holdings stock sector shares held market value rank source source date unknown unknown    d  diffusion pharmaceut dffn consumer discretionary    d  aevi genomic medicine inc gnmx health care    d  contrafect corp cfrx health care    g  proelite inc pele consumer discretionary    d  greenhouse holdings inc grhu industrials    d  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft loading your search results  peoplelookercom updating data on  please wait  seconds more okay online background checks  beenverified × beenverifiedcom looking to find out about someone so have the  people who have tried beenverified start here  try searching a friend relative date neighbor or even yourself people phone email property we respect your privacy first name last name state all states alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming   search phone number   search email address   search street address   search we respect your privacy  reports  counting address lookup  property search  beenverifiedcom public data for personal matters questions  login every address tells a story search millions of property values deeds owners transactions and more search property records search millions of property values deeds owners transactions and more see who owns a property search millions of property values deeds owners transactions and more search mortgage records search millions of property values deeds owners transactions and more search property deeds search millions of property values deeds owners transactions and more every address tells a story search property owners records and more who owns this property search millions of property values deeds owners transactions and more start here  try searching your home your neighbors or another address address   search know the name of a property owner find out about them here search by owners name property data can help you find a home you will have access to data about property values sales prices loans deed history nearby sex offenders and much more connect with owners unlike other property websites beenverified will help you connect with the owners of every address go beyond the address your first property search opens the door to billions of public records about people places phone numbers and online identities the intersection of data and the real world beenverified helps you incorporate property records and public data into your life         reports run by users  b i l l i o n  public data points billions of records at your fingertips with over  downloads so far beenverified is the goto choice for mobile public data access incredibly simple to use and useful this app has saved the day on finding so many addresses i needed definitely recommend”   via the app store always improving beenverified is relentless in its pursuit of providing you with better public data search an address reverse property reverse address lookup search millions of property values deeds owners transactions and more start here try searching your home your neighbors or another address search we respect your privacy what makes us different property data  people data our reports include the traditional info you’d expect to find about a property ownership deeds tax info etc but we dig deeper and offer background records on people too find criminal background records on owners registered sex offenders in the neighborhood and more the extras we include for free run criminal background checks on previous owners their associates or the neighbors get to know the whole story know your new neighborhood by seeing sex offender information which may include names addresses and criminal convictions easy to use reporting just enter an address a name or even a phone number and we will give you all the information we have “excellent support  service”  via sitejabbercom  supportbeenverifiedcom mon  fri  am   pm estsat  sun  am   pm est our goal is to provide helpful support that is quick and easy carla director of customer service about us about bv people search testimonials careers leadership press white pages criminal records our apps all bv apps for iphone  ipad  download for apple watch  download for android  download developer api help support contact us dos  donts faq remove my info affiliates glossary disclaimer beenverified’s mission is to give people easy and affordable access to public record information beenverified does not provide private investigator services and is not a consumer reporting agency as defined by the fair credit report act because the information provided by beenverified is not collected or provided in whole or in part for the purpose of furnishing consumer reports about those search subjects for more information governing the permitted and prohibited uses of beenverified please review our “do’s  don’ts” and our terms  conditions beenverified   all rights reserved terms  conditions privacy policy background checks  public records  beenverified   × beenverifiedcom welcome to beenverified from beenverified on vimeo search people  public records try searching a friend relative or even yourself the choice is yours people phone email property we respect your privacy first name last name state all states alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming   search phone number   search email address   search street address   search   are you a business user try knowthycustomercom  successful people reports easy and affordable background checks learn why millions of people search beenverified unlimited searches anytime looking for someone our intuitive public records search engine makes it easy see our dos and donts affordable  accessible we dont want you to ask yourself if its worth it to run a search respect for privacy a privacyfriendly public record search is not an oxymoron learn how we do it public records in one easy report search for what you are looking for and get all the data we find in one single report learn about us beenverified for business imagine the power of beenverifieds massive public record database working for your business thats bv pro why bv pro enterprise apis perfect for teams batch processing customizable what is it for prevent fraud scrub records reach customers client relations try bv pro not sure check out our “do’s  don’ts” experience the beenverified difference see what people like you are saying about beenverified natasha oklahoma nursing student my daughter recently went out for soccer i decided it would be a good idea to run another player’s father through beenverified turns out this guy had been charged with indecent exposure and was on parole maryann new jersey analyst i used beenverified to check into a guy that i had met online it turns out he had lied to me about where he lived and his family needless to say thanks to bv i severed contact with him and have not heard from him since thank you bv bob m new jersey retired detective i am retired and have a ministry helping the dying and sick i found a son and the mother was dying of cancer she held on waiting for her son who had not been in touch for years rhonda missouri caring mom im a single mother dating online and i use beenverified to help protect my family more testimonials from the press gizmodocom it found my photos on flickr my amazon wishlist my public foursquare records vimeo picassa and stumbleupon accounts it grabbed approximately twelve bajillion photos of me with many many false positives and even more web links from the press us news  world report beenverified easily and inexpensively provides access to public records information through its website and several mobile phone applications no longer are large corporations the only ones who can afford background checks from the press nbc  miami instant information… court documents mortgage deeds criminal records right in the palm of your hand more press quotes billions of records at your fingertips with over  downloads so far beenverified is the goto choice for mobile public data access great app   beenverified is easy to use and provides the details needed for a reliable accurate background check highly recommend”  via the app store what are you waiting forsearch someone